Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-05-01 5:08 pm Unchanged | 13G | EYEPOINT PHARMACEUTICALS, INC. EYPT | Adage Capital Management L.P. | 5,156,299 9.9% | 0 (Unchanged) | View |
| 2024-04-30 8:53 pm Purchase | 13G | EYEPOINT PHARMACEUTICALS, INC. EYPT | Adage Capital Management L.P. | 5,156,299 10.35% | 5,156,299 (New Position) | View |
| 2024-04-05 4:05 pm Purchase | 13D | ARCA BIOPHARMA INC PAR $.0 ABIO | Adage Capital Management L.P. | 1,200,000 8.28% | 1,200,000 (New Position) | View |